Cancer is a group of diseases characterized by uncontrolled cell growth. While some cancers are common, others are rare, affecting fewer than 200,000 people in the United States. The Orphan Drug Act of 1983 provides incentives to companies that develop treatments for these rare cancers, ensuring that patients have access to potentially lifesaving therapies.
